HREC and TGA Approval to Commence Phase 3 in Australia
Filed with ASX · · 3 pages · English
Invex Therapeutics Ltd. on 6ix
Story so far
Earlier from Invex Therapeutics
- Invex Receives UK Approval to Commence Phase III Trial
- Half Yearly Report and Accounts
- New Executive Director and Chairman Agreements
- Appointment IIH EVOLVE Phase III Trial Steering Group Chair
- Invex Therapeutics: Chairman's Address to Shareholders at AGM
Later from Invex Therapeutics
- Quarterly Activities/Appendix 4C Cash Flow Report
- Invex receives IND approval
- 4E and Annual Report to shareholders
- Second HREC Approval for IIH EVOLVE Phase III Clinical Trial
- First Australian Site Activated in IIH EVOLVE Phase 3
Follow Invex Therapeutics into a list and get an email when it puts out news.
Follow Invex Therapeutics